Pros

New Analyses of the MIRROR Randomized Controlled Trial in Uncontrolled Gout Presented at the 2023 EULAR European Congress of Rheumatology

Retrieved on: 
Wednesday, May 31, 2023

Presentations are part of expert discussions at the EULAR European Congress of Rheumatology , May 31 - June 3, 2023, in Milan.

Key Points: 
  • Presentations are part of expert discussions at the EULAR European Congress of Rheumatology , May 31 - June 3, 2023, in Milan.
  • Data presented from Horizon’s MIRROR randomized controlled trial (RCT), which evaluated KRYSTEXXA in combination with methotrexate for uncontrolled gout, provide further evidence of the impact of therapy on patient-reported outcomes (PROs), urate depletion and bone remodeling.
  • “Uncontrolled gout is far more painful and dangerous than most people know,” said Brian LaMoreaux, M.D., M.S., senior medical director, Horizon.
  • Bone erosion remodeling after depletion of monosodium urate deposition with intensive urate-lowering with pegloticase in patients with uncontrolled gout: MIRROR RCT dual-energy CT findings (POS0514)

GNC Turns Up the Summer Heat with New GNC AMP Amplified Hydration from GNCX Innovations

Retrieved on: 
Tuesday, May 30, 2023

PITTSBURGH, May 30, 2023 /PRNewswire/ -- As summer rolls in, hydration should be top-of-mind. Whether consumers are hitting a hard workout or vacationing in the sun, hydration enables performance, endurance, and overall wellness. And that's why GNC just dropped its first functional hydration and performance product: GNC AMP Amplified Hydration. This enhanced electrolyte complex is designed to support hydration, recovery and multi-action digestion in stick packs that can be mixed in water. The first drop, now available online and in GNC stores, features seasonal flavors acai berry, tropical punch and lemon lime all of which were created within GNCX Innovations, its in-house innovation incubator creating science-backed products.

Key Points: 
  • And that's why GNC just dropped its first functional hydration and performance product: GNC AMP Amplified Hydration.
  • "Our new GNC products have the power to drive performance in the gym and dominate days off," said Kevin Maloberti, VP, Merchandising at GNC.
  • "GNC AMP Amplified Hydration is the first launch from our groundbreaking GNCX Innovations incubator and was developed with feedback from our most passionate consumers," Maloberti continued.
  • In addition to GNC AMP Amplified Hydration, GNC is launching other limited time flavors including:
    AMP Wheybolic Whey Protein: This classic whey protein powder is now available in a nostalgic, campfire-inspired S'mores flavor.

boombox.io Raises $7M to Build Out Creator Platform for Music Makers

Retrieved on: 
Tuesday, May 23, 2023

SAN FRANCISCO, May 23, 2023 /PRNewswire/ -- boombox.io, a collaboration platform for music makers, announced today it has closed $7 million of seed capital. The round was led by Forerunner with participation from super{set} startup studio and Ulu Ventures.

Key Points: 
  • SAN FRANCISCO, May 23, 2023 /PRNewswire/ -- boombox.io , a collaboration platform for music makers, announced today it has closed $7 million of seed capital.
  • "As a musician and engineer, I felt the creator economy was long on hype and short on tools for creators.
  • We aspired to build a platform that gives music makers an all-in-one platform to collaborate like GitHub, connect like LinkedIn, and earn revenue from music," said co-founder and CEO Tom Chavez.
  • It's like Dropbox on steroids but with so much more, built by people who know how music is made."

Phreesia’s Hilary Hatch Named a “Disrupter” in PM360’s ELITE 100

Retrieved on: 
Tuesday, May 16, 2023

Phreesia is pleased to announce that Hilary Hatch, PhD, Phreesia’s Chief Clinical Officer, has been named as one of the 2023 PM360 ELITE 100 by healthcare-marketing trade publication, PM360.

Key Points: 
  • Phreesia is pleased to announce that Hilary Hatch, PhD, Phreesia’s Chief Clinical Officer, has been named as one of the 2023 PM360 ELITE 100 by healthcare-marketing trade publication, PM360.
  • This year’s ELITE 100 were chosen from among 500 submissions across 19 categories.
  • The PM360 ELITE Awards recognize individuals and teams who have made a significant impact on the healthcare industry.
  • Winners are selected by the PM360 editorial staff based on their career accomplishments and the influence they’ve had on the industry.

2seventy bio Announces Additional Data from KarMMa Studies of Abecma (idecabtagene vicleucel) at ASCO 2023 and EHA 2023

Retrieved on: 
Thursday, May 11, 2023

The presentations will highlight clinical and correlative data from the KarMMa-2 and KarMMa-3 clinical trials evaluating Abecma (idecabtagene vicleucel) in patients with relapsed and/or refractory multiple myeloma (RRMM) or newly diagnosed multiple myeloma.

Key Points: 
  • The presentations will highlight clinical and correlative data from the KarMMa-2 and KarMMa-3 clinical trials evaluating Abecma (idecabtagene vicleucel) in patients with relapsed and/or refractory multiple myeloma (RRMM) or newly diagnosed multiple myeloma.
  • “These data highlight the growing body of evidence that further support the value of Abecma across various subgroups of patients with triple-class-exposed relapsed and/or refractory multiple myeloma, who, despite recent advancements, still need more effective treatment options sooner,” said Steve Bernstein, M.D., chief medical officer, 2seventy bio.
  • Additional analysis of outcomes by number of prior lines of therapy from the KarMMa-3 clinical trial showcasing the use of Abecma in patients who received two to four prior lines of therapy.
  • Patient-reported outcomes from the pivotal Phase 3 KarMMa-3 trial in patients with triple-class exposed RRMM treated with Abecma versus standard regimens.

Frontdoor Surpasses 225,000 Downloads in First Month!

Retrieved on: 
Wednesday, May 10, 2023

Frontdoor, Inc. (NASDAQ: FTDR), the nation’s leading provider of home service plans, announced today that Frontdoor, the one-stop-app for all things home maintenance and repair, has reached over 225,000 downloads in just the four weeks since it launched on April 11.

Key Points: 
  • Frontdoor, Inc. (NASDAQ: FTDR), the nation’s leading provider of home service plans, announced today that Frontdoor, the one-stop-app for all things home maintenance and repair, has reached over 225,000 downloads in just the four weeks since it launched on April 11.
  • If you like the Basic experience, you can upgrade to Frontdoor Prime for additional benefits at just $99 a year.
  • The reports filed by Frontdoor pursuant to United States securities laws contain discussions of these risks and uncertainties.
  • Frontdoor assumes no obligation to, and expressly disclaims any obligation to, update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Boulo Solutions Founder Shares Expertise at Second Annual Governor's Summit on Talent Retention and Work-based Learning

Retrieved on: 
Wednesday, May 3, 2023

BIRMINGHAM, Ala., May 3, 2023 /PRNewswire/ -- Boulo Solutions' founder and CEO Delphine Carter will share her front-line insights during a panel discussion on "The Pros and Cons of Working Remotely" at the Second Annual Governor's Summit on Talent Retention and Work-based Learning. Boulo Solutions is the recruiting industry's go-to resource connecting results-driven employers with a diverse talent pool—including women, mothers, and caregivers—looking for flexibility.

Key Points: 
  • BIRMINGHAM, Ala., May 3, 2023 /PRNewswire/ -- Boulo Solutions ' founder and CEO Delphine Carter will share her front-line insights during a panel discussion on "The Pros and Cons of Working Remotely" at the Second Annual Governor's Summit on Talent Retention and Work-based Learning .
  • Boulo Solutions is the recruiting industry's go-to resource connecting results-driven employers with a diverse talent pool—including women, mothers, and caregivers—looking for flexibility.
  • Boulo Solutions matches growth-mind employers with the talent they need to succeed.
  • The firm advocates for flexible work arrangements to reach "hidden talent" not found on traditional job boards or applying to company postings.

National Storage Affiliates Trust Reports First Quarter 2023 Results

Retrieved on: 
Monday, May 1, 2023

National Storage Affiliates Trust ("NSA" or the "Company") (NYSE: NSA) today reported the Company’s first quarter 2023 results.

Key Points: 
  • National Storage Affiliates Trust ("NSA" or the "Company") (NYSE: NSA) today reported the Company’s first quarter 2023 results.
  • Reported net income of $40.4 million for the first quarter of 2023, a decrease of 9.8% compared to the first quarter of 2022.
  • Reported diluted earnings per share of $0.24 for the first quarter of 2023 compared to $0.24 for the first quarter of 2022.
  • Acquired 16 wholly-owned self storage properties for approximately $160.5 million during the first quarter of 2023.

Life Spine Releases Published Article on the Effect of Expandable Versus Static Lordotic Interbody Implants in Minimally Invasive Spine Surgery

Retrieved on: 
Tuesday, April 18, 2023

Life Spine, a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spinal disorders, announced today that the Company has published a new retrospective study examining the effect of expandable versus static interbody implants via the Journal of Spine Surgery (JSS).

Key Points: 
  • Life Spine, a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spinal disorders, announced today that the Company has published a new retrospective study examining the effect of expandable versus static interbody implants via the Journal of Spine Surgery (JSS).
  • The paper assessed the results of 100 patients who underwent transforaminal lumbar spinal fusion via minimally invasive surgery at L4-L5 or L5-S1.
  • “ProLift and our full line of Micro Invasive expandable products have received excellent feedback from surgeons.
  • This study validates that feedback and demonstrates significantly improved radiographic and PROs compared to the static cage.

The SPHERES Registry of Patients with NMOSD Reaches Enrollment Milestone of 200 Patients

Retrieved on: 
Wednesday, April 12, 2023

The SPHERES Registry has recruited 200 patients, across 23 sites in North America, supported by 72 physicians.

Key Points: 
  • The SPHERES Registry has recruited 200 patients, across 23 sites in North America, supported by 72 physicians.
  • Launched in early 2021, the SPHERES Registry serves as the first regulatory-grade and real-world study to advance the understanding of NMOSD.
  • To date, the SPHERES Registry has recruited 200 patients, across 23 sites in North America, supported by 72 physicians.
  • Today, advances in diagnosis, biomarkers, and newly FDA-approved treatment options offer patients with NMOSD the promise to lessen or prevent disability and enhance quality of life.